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Background
Alpha-fetoprotein (AFP) is an oncofetal antigen expressed
by over 50% of hepatocellular carcinoma (HCC) tumors.
AFP-L3 is the major isoform present in the serum of HCC
patients and is associated with poor patient prognosis.
While HCC tumor-derived AFP (tAFP) contains >80% of
AFP-L3, cord blood serum-derived AFP (nAFP) contains
less than 5% of AFP-L3. Previous studies have proposed
an immunoregulatory role for AFP on myeloid cells
including dendritic cells (DC).
Methods
Therefore, to test the specific effect of nAFP and tAFP on
DC differentiation in vitro, peripheral blood monocytes
from healthy donors were cultured in the presence of
nAFP or tAFP, and DC phenotype and function was
assessed after 5 days. We have previously shown that
monocytes cultured in vitro in the presence of tAFP differ-
entiated into DC that retained a monocyte-like morphol-
ogy, had decreased expression of surface DC maturation
markers, exhibited limited production of inflammatory
cytokines, and failed to induce robust T cell proliferative
responses. Here, we investigate the mechanisms of tAFP-
induced suppressive effects on monocyte-derived DC.
Specifically: i) CD1 family surface expression, ii) che-
mokine production, and iii) DC metabolism.
Results
Our results show that 5 days after culture, the mRNA
and surface expression of CD1a, CD1b, CD1c and CD1d
are reduced in nAFP-DC and are further reduced in
tAFP-DC. We also show that tAFP-DC had decreased
secretion of chemokines CCL1, CCL2, CCL3, CCL4,
CCL17, CCL20 and CCL22 in day 6 and/or day 7 super-
natants on a per cell basis. Most importantly, we observe
reduced mitochondrial mass and a significant defect in
mitochondrial oxidative phosphorylation and inhibition
of glycolysis in tAFP-DC compared to OVA-DC or
nAFP-DC.
Conclusions
Collectively, these data show profound negative effects of
tAFP on DC function. These results help explain some of
the immune suppression observed in AFP+ HCC patients
and may lead to novel therapeutic approaches to reverse
these immunosuppressive effects to improve DC function
and enhance anti-HCC immunity.
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